Kolaz Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 30-12-2024
- Paid Up Capital ₹ 0.30 M
as on 30-12-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.54 Cr
as on 30-12-2024
- Satisfied Charges ₹ 6.70 M
as on 30-12-2024
- Revenue 1.49%
(FY 2021)
- Profit 8.28%
(FY 2021)
- Ebitda -27.44%
(FY 2021)
- Net Worth 36.39%
(FY 2021)
- Total Assets 17.25%
(FY 2021)
About Kolaz Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹2.54 Cr. The company has closed loans amounting to ₹6.70 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Bhardwaj, Sandeep Middha, and Rajeev Madan serve as directors at the Company.
- CIN/LLPIN
U24100HR2014PTC052312
- Company No.
052312
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2014
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationAmbala Cantt, Haryana
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kolaz Biotech Private Limited offer?
Kolaz Biotech Private Limited offers a wide range of products and services, including Pharma Franchise, PCD Pharma Franchise, Pharmaceutical Distributors.
Who are the key members and board of directors at Kolaz Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Bhardwaj  | Director | 31-Mar-2014 | Current |
| Sandeep Middha | Director | 31-Mar-2014 | Current |
| Rajeev Madan | Director | 31-Mar-2014 | Current |
Financial Performance of Kolaz Biotech.
Kolaz Biotech Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 1.49% increase. The company also saw a slight improvement in profitability, with a 8.28% increase in profit. The company's net worth Soared by an impressive increase of 36.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kolaz Biotech?
In 2021, Kolaz Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medok Lifesciences Private LimitedActive 14 years 11 monthsAjay Bhardwaj, Sandeep Middha and 1 more are mutual person
Bioglaze Biotech Private LimitedActive 6 years 7 monthsAjay Bhardwaj, Sandeep Middha and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Sep 2024 | ₹2.00 M | Open |
Others Creation Date: 23 Aug 2024 | ₹1.31 Cr | Open |
Canara Bank Creation Date: 21 Nov 2023 | ₹1.03 Cr | Open |
How Many Employees Work at Kolaz Biotech?
Unlock and access historical data on people associated with Kolaz Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kolaz Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kolaz Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
